These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27796699)

  • 1. Skin Necrosis Following Subcutaneous Immunoglobulin (SCIg).
    Carne E; Ponsford M; El-Shanawany T; Jolles S
    J Clin Immunol; 2017 Jan; 37(1):27-28. PubMed ID: 27796699
    [No Abstract]   [Full Text] [Related]  

  • 2. The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).
    Ameratunga R; Ahn Y; Steele R; Woon ST
    Front Immunol; 2019; 10():1541. PubMed ID: 31379811
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of skin necrosis with subcutaneous immunoglobulin therapy.
    Datta R; Kuruvilla M; Gill M; de la Morena MT
    Ann Allergy Asthma Immunol; 2014 Aug; 113(2):232-3. PubMed ID: 24996991
    [No Abstract]   [Full Text] [Related]  

  • 4. Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency.
    Pedini V; Savore I; Danieli MG
    Isr Med Assoc J; 2017 Jul; 19(7):420-423. PubMed ID: 28786256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Experiences With Facilitated Subcutaneous Immunoglobulin Substitution in Patients With Hypogammaglobulinemia, Using a Three-Step Ramp-Up Schedule.
    Hustad NB; Degerud HM; Hjelmerud I; Fraz MSA; Nordøy I; Trøseid M; Fevang B; Aukrust P; Jørgensen SF
    Front Immunol; 2021; 12():670547. PubMed ID: 34012453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granuloma-like lesion at subcutaneous immunoglobulin site in a common variable immunodeficiency patient.
    Gupta A; Wang B; Gupta S
    Immunotherapy; 2019 Oct; 11(14):1177-1180. PubMed ID: 31478429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitated subcutaneous immunoglobulin (fSCIg) therapy--practical considerations.
    Ponsford M; Carne E; Kingdon C; Joyce C; Price C; Williams C; El-Shanawany T; Williams P; Jolles S
    Clin Exp Immunol; 2015 Dec; 182(3):302-13. PubMed ID: 26288095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration.
    Quinti I; Soresina A; Agostini C; Spadaro G; Matucci A; Sfika I; Martini H; Borghese F; Guerra A; Alessandra V; Visentini M; Plebani A; Fiorilli M
    J Clin Immunol; 2008 May; 28(3):263-7. PubMed ID: 18214651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to the Letter to the Editor Regarding "Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials".
    Suez D; Stein M; Gupta S; Hussain I; Melamed I; Paris K; Darter A; Bourgeois C; Fritsch S; Leibl H; McCoy B; Gelmont D; Yel L
    J Clin Immunol; 2017 Nov; 37(8):739-740. PubMed ID: 28875256
    [No Abstract]   [Full Text] [Related]  

  • 10. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.
    Ameratunga R; Woon ST; Gillis D; Koopmans W; Steele R
    Clin Exp Immunol; 2013 Nov; 174(2):203-11. PubMed ID: 23859429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women.
    Gardulf A; Andersson E; Lindqvist M; Hansen S; Gustafson R
    J Clin Immunol; 2001 Mar; 21(2):150-4. PubMed ID: 11332654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of 20% subcutaneous immunoglobulin in pregnant women with primary immune deficiency.
    Duff C; Krishnaswamy G; Ghably J
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):83-5. PubMed ID: 26707772
    [No Abstract]   [Full Text] [Related]  

  • 13. Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases.
    Haddad É; Barnes D; Kafal A
    Transfus Apher Sci; 2012 Jun; 46(3):315-21. PubMed ID: 22503304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pityriasis lichenoides et varioliformis acuta associated with subcutaneous immunoglobulin administration.
    Machan M; Loren R; Fraga G; Liu D
    J Am Acad Dermatol; 2012 Oct; 67(4):e151-2. PubMed ID: 22980275
    [No Abstract]   [Full Text] [Related]  

  • 15. [Subcutaneous gammaglobulin in common variable immunodeficiency. First experience in Spain].
    Maroto Hernando M; Soler Palacín P; Martin Nalda N; Oliveras Arenas M; Español Boren T; Figueras Nadal C
    An Pediatr (Barc); 2009 Feb; 70(2):111-9. PubMed ID: 19217565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study.
    Pulvirenti F; Cinetto F; Pecoraro A; Carrabba M; Crescenzi L; Neri R; Bonanni L; Fabio G; Agostini C; Spadaro G; Tabolli S; Farrugia A; Quinti I; Milito C
    J Clin Immunol; 2019 Feb; 39(2):159-170. PubMed ID: 30644015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.
    Stein MR; Koterba A; Rodden L; Berger M
    Postgrad Med; 2011 Sep; 123(5):186-93. PubMed ID: 21904101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials.
    Ballow M; Wasserman RL; Jolles S; Chapel H; Berger M; Misbah SA
    J Clin Immunol; 2017 Aug; 37(6):517-518. PubMed ID: 28695366
    [No Abstract]   [Full Text] [Related]  

  • 19. A young woman with diffuse skin lesions.
    Mansouri N; Kamali M; Marjani M; Tabarsi P; Sajadi MM; Mansouri D
    Clin Infect Dis; 2010 Jul; 51(2):195-6; anwer 248-9. PubMed ID: 20560733
    [No Abstract]   [Full Text] [Related]  

  • 20. A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement.
    Więsik-Szewczyk E; Jahnz-Różyk K
    Medicine (Baltimore); 2018 Nov; 97(44):e12804. PubMed ID: 30383634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.